Cooper Daniel J, Rajahram Giri S, William Timothy, Jelip Jenarun, Mohammad Rashidah, Benedict Joseph, Alaza Danshy A, Malacova Eva, Yeo Tsin W, Grigg Matthew J, Anstey Nicholas M, Barber Bridget E
Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah.
Clin Infect Dis. 2020 Jan 16;70(3):361-367. doi: 10.1093/cid/ciz237.
Malaysia aims to eliminate malaria by 2020. However, while cases of Plasmodium falciparum and Plasmodium vivax have decreased substantially, the incidence of zoonotic malaria from Plasmodium knowlesi continues to increase, presenting a major challenge to regional malaria control efforts. Here we report incidence of all Plasmodium species in Sabah, including zoonotic P. knowlesi, during 2015-2017.
Microscopy-based malaria notification data and polymerase chain reaction (PCR) results were obtained from the Sabah Department of Health and State Public Health Laboratory, respectively, from January 2015 to December 2017. From January 2016 this was complemented by a statewide prospective hospital surveillance study. Databases were matched, and species was determined by PCR, or microscopy if PCR was not available.
A total of 3867 malaria cases were recorded between 2015 and 2017, with PCR performed in 93%. Using PCR results, and microscopy if PCR was unavailable, P. knowlesi accounted for 817 (80%), 677 (88%), and 2030 (98%) malaria cases in 2015, 2016, and 2017, respectively. P. falciparum accounted for 110 (11%), 45 (6%), and 23 (1%) cases and P. vivax accounted for 61 (6%), 17 (2%), and 8 (0.4%) cases, respectively. Of those with P. knowlesi, the median age was 35 (interquartile range: 24-47) years, and 85% were male.
Malaysia is approaching elimination of the human-only Plasmodium species. However, the ongoing increase in P. knowlesi incidence presents a major challenge to malaria control and warrants increased focus on knowlesi-specific prevention activities. Wider molecular surveillance in surrounding countries is required.
马来西亚的目标是到2020年消除疟疾。然而,虽然恶性疟原虫和间日疟原虫的病例已大幅减少,但诺氏疟原虫引起的人兽共患疟疾的发病率仍在持续上升,这对区域疟疾控制工作构成了重大挑战。在此,我们报告了2015年至2017年沙巴州所有疟原虫种类的发病率,包括人兽共患的诺氏疟原虫。
基于显微镜检查的疟疾通报数据和聚合酶链反应(PCR)结果分别来自沙巴州卫生部和州公共卫生实验室,时间跨度为2015年1月至2017年12月。从2016年1月起,一项全州范围的前瞻性医院监测研究对上述数据进行了补充。对数据库进行匹配,通过PCR确定疟原虫种类,若无法进行PCR检测,则通过显微镜检查确定。
2015年至2017年期间共记录了3867例疟疾病例,其中93%进行了PCR检测。根据PCR结果,并在无法进行PCR检测时结合显微镜检查结果,2015年、2016年和2017年诺氏疟原虫导致的疟疾病例分别为817例(80%)、677例(88%)和2030例(98%)。恶性疟原虫导致的病例分别为110例(11%)、45例(6%)和23例(1%),间日疟原虫导致的病例分别为61例(6%)、17例(2%)和8例(0.4%)。感染诺氏疟原虫的患者中位年龄为35岁(四分位间距:24 - 47岁),85%为男性。
马来西亚正在接近消除仅感染人类的疟原虫种类。然而,诺氏疟原虫发病率的持续上升对疟疾控制构成了重大挑战,有必要更加关注针对诺氏疟原虫的预防活动。周边国家需要开展更广泛的分子监测。